{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:19:02Z","timestamp":1768925942915,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0204-6","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T19:33:15Z","timestamp":1458329595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"An- Ning","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Yuh","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"issue":"12","key":"204_CR1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hyg113","volume":"33","author":"A Kaneko","year":"2003","unstructured":"Kaneko A, Suzuki S. Eye preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncolo. 2003;33(12):601\u20137.","journal-title":"Jpn J Clin Oncolo"},{"issue":"4","key":"204_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","volume":"35","author":"FL Munier","year":"2014","unstructured":"Munier FL. Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August24th 2013. Ophthalmic Genetics. 2014;35(4):193\u2013207.","journal-title":"Ophthalmic Genetics"},{"issue":"3","key":"204_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","volume":"132","author":"CL Shields","year":"2014","unstructured":"Shields CL, Manjandavida FP, Areoalli S, Kaliki S, Lallly SE, Shields JA. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds. Preliminary results. JAMA Ophthalmol. 2014;132(3):319\u201325.","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"204_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjophthalmol-2013-303885","volume":"98","author":"SJ Smith","year":"2014","unstructured":"Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2014;98(3):292\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"204_CR5","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","volume":"130","author":"CL Shields","year":"2012","unstructured":"Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seedings from retinoblastoma. Arch Ophthalmol. 2012;130(10):1268\u201371.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"204_CR6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","volume":"96","author":"FL Munier","year":"2012","unstructured":"Munier FL, Soliman S, Moulin AP, Galliard MC, Balmer A, Beck-Popovic M. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilization of the needle track. Br J Ophthalmol. 2012;96(8):1084\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"204_CR7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","volume":"59","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A. Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol. 2015;59(3):164\u201372.","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"204_CR8","first-page":"858","volume":"78","author":"M Inomata","year":"1987","unstructured":"Inomata M, Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res. 1987;78(8):858\u201368.","journal-title":"Jpn J Cancer Res"},{"issue":"11","key":"204_CR9","first-page":"1230","volume":"99","author":"M Ueda","year":"1995","unstructured":"Ueda M, Tanabe J, Inomata M, Kaneko A, Kimura T. Study on conservative treatment of retinoblastoma-- effect of intravitreal injection of melphalan on the rabbit retina. Nippon Ganka Gakkai Zasshi. 1995;99(11):1230\u20135. Article in Japanese.","journal-title":"Nippon Ganka Gakkai Zasshi"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0204-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T08:37:20Z","timestamp":1498293440000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2415\/16\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0204-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]},"article-number":"27"}}